ConductScience.org, home

Paper7436166

Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure.

Colucci WS and 2 others. Ann Intern Med, 1980. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. Papers, record 7436166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7436166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure.
PubMed
Journal
Ann Intern Med
PubMed
Year
1980
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.89
iCite
Revised in PubMed
2019-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Colucci WSW S
2Williams GHG H
3Braunwald EE

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
NorepinephrineMajor topic
PrazosinMajor topic
QuinazolinesMajor topic
Vasodilator AgentsMajor topic
Humans
Posture
Sympathetic Nervous System
Time Factors

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HL 05832NHLBI NIH HHSUnited StatesPubMedPubMed
HL 16821NHLBI NIH HHSUnited StatesR01HL016821PubMed and NIHNIH RePORTER
HL 1882NHLBI NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
39076631The Remaining Conundrum of the Role of the Na+/H+ Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified?Rev Cardiovasc Med2022https://conductscience.org/library/papers/39076631PubMed
23989716Adrenergic nervous system in heart failure: pathophysiology and therapy.Circ Res2013https://conductscience.org/library/papers/23989716PubMed
22919539Central mechanisms of abnormal sympathoexcitation in chronic heart failure.Cardiol Res Pract2012https://conductscience.org/library/papers/22919539PubMed
21919922Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.Alcohol Clin Exp Res2012https://conductscience.org/library/papers/21919922PubMed
16228919The control of adrenergic function in heart failure: therapeutic intervention.Heart Fail Rev2000https://conductscience.org/library/papers/16228919PubMed
16228912Alterations in adrenergic receptor signaling in heart failure.Heart Fail Rev2000https://conductscience.org/library/papers/16228912PubMed
12097149A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy.Curr Control Trials Cardiovasc Med2002https://conductscience.org/library/papers/12097149PubMed
7317235Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.Br Heart J1981https://conductscience.org/library/papers/7317235PubMed
6349967Vasodilator therapy in chronic congestive heart failure.Drugs1983https://conductscience.org/library/papers/6349967PubMed
6088579Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.J Clin Invest1984https://conductscience.org/library/papers/6088579PubMed
3924285Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3924285PubMed
3552590The role of vasodilator therapy in the treatment of severe chronic heart failure.Drugs1986https://conductscience.org/library/papers/3552590PubMed
2535057Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2535057PubMed
1358918Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans.J Clin Invest1992https://conductscience.org/library/papers/1358918PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7436166

GET https://conductscience.org/api/papers/v1/7436166/authors